Changes of BMD and QUS in relation to VDR rs1544410 genotype (mean ± SD) Bonferroni post-ANOVA TEST.

<p>^a Adjusted for age, weight, height, percentage weight change per year, baseline BMD and calcium intake.</p><p>Changes of BMD and QUS in relation to VDR rs1544410 genotype (mean ± SD) Bonferroni post-ANOVA TEST.</p

Subject characteristics at Follow-Up visit by VDR rs1544410 Genotype.

<p>Subject characteristics at Follow-Up visit by VDR rs1544410 Genotype.</p

Partial correlations between LCO3-PUFAs intake and bone mineral density in normal women according to the WHO diagnosis criteria for osteoporosis.

<p>Partial correlations between LCO3-PUFAs intake and bone mineral density in normal women according to the WHO diagnosis criteria for osteoporosis.</p

Multiple linear regression analysis for the association between BMD at the femoral neck and age, BMI, calcium intake, vitamin D intake, menopausal status and total LCO3-PUFA intake according to the WHO diagnosis criteria for osteoporosis.

<p>Multiple linear regression analysis for the association between BMD at the femoral neck and age, BMI, calcium intake, vitamin D intake, menopausal status and total LCO3-PUFA intake according to the WHO diagnosis criteria for osteoporosis.</p

Bivariate and partial correlations between LCO3-PUFAs and bone mineral density.

<p>Bivariate and partial correlations between LCO3-PUFAs and bone mineral density.</p

Dietary intake of EPA and DHA according to the WHO diagnosis criteria for osteoporosis.

<p>Bars represents mean±C.I 95%. Significant differences were found for the EPA and DHA intake between normal vs osteoporosis and for osteopenia vs osteoporosis groups; p-values after further adjustment by energy intake (kcal/day) (ANCOVA test).</p

Bone mineral density of premenopausal and postmenopausal subjects.

<p>Bone mineral density of premenopausal and postmenopausal subjects.</p